Chinese scientists have made an extremely important development in medicine. Researchers conducting a new study for lung cancer, which has a very high mortality rate, developed a method that can detect this cancer “in advance”.
Researchers, who have accelerated their work especially in recent weeks, have developed a blood test that can detect lung cancer in advance with samples taken from real lung patients. The accuracy of this test, which is a new light for the scientific world, is very promising.
One milliliter of blood is enough to detect lung cancer.
As you know, detecting cancer in its early stages is vital for patients. Scientists, who have been trying for many years both to detect cancer at an early stage and to find a cure, have slowly started to reap the rewards of their work.
Chinese scientists used tumor samples from real lung cancer patients for the blood test they developed to detect lung cancer early. By sequencing the genetics of these tumors, the researchers identified nine different types of molecules that could later be used as signs of lung cancer.
According to the statement, this test, which has been studied for a long time, has been named Lung Cancer Artificial Intelligence Detector (LCAID). It was stated that the accuracy rate of the test, in which only one milliliter of blood was sufficient, was 90%, and the rate of staging specifically was 92%.
This improvement may minimize the need for low-dose tomography
Low-dose computed tomography is currently one of the most common methods used to detect lung cancer. However, this screening is only applied to people over a certain age who have a history of smoking.
Yuxin Yin, one of the lead authors of the study, states that non-smokers can also get lung cancer and underlines that the Lung Cancer Artificial Intelligence Detector can be used by anyone, regardless of smoking history and age.
Yin also stated that they need more research and studies to make the Lung Cancer Artificial Intelligence Detector available to everyone in clinical settings, and that they will seek regulatory approval for the test from the Chinese government in the future.
28452
